Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7250
-0.0234 (-3.13%)
Sep 28, 2026, 3:34 PM EDT - Market open
Rein Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Gross Profit Gross Profit Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.17 | - | - | - |
Operating Income Operating Income Growth | -20.76 | -21.55 | -21.93 | -23.77 | -24.35 | -26.52 | -28.11 | -29.62 | -25.52 | -18.56 | -15.35 | -12.75 | -17.25 | -23.22 | -27.65 | -29.76 | -30.07 | -28.04 | -26.61 | -23.98 |
Net Income Net Income Growth | -49.76 | -50.21 | -49.87 | -58.89 | -59.15 | -61.27 | -62.88 | -29.24 | -25.22 | -18.07 | -15.73 | -12.94 | -17.48 | -23.69 | -27.33 | -29.58 | -29.92 | -27.61 | -26.16 | -24.36 |
Earnings Per Share EPS Growth | -1.30 | -1.82 | -1.96 | -2.50 | -2.64 | -2.87 | -3.51 | -2.13 | -2.68 | -3.26 | -3.42 | -2.85 | -3.85 | -5.22 | -6.02 | -6.52 | -6.60 | -6.10 | -5.89 | -6.38 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 40.65 | 4.45 | 3.22 | 4.05 | 5.72 | 7.43 | 12.87 | 17.65 | 21.92 | 12.04 | 17.31 | 12.07 | 13.67 | 16.72 | 21.24 | 25.48 | 32.38 | 38.08 | 45.93 | 52.23 |
Total Debt Total Debt Growth | - | 4.92 | - | - | - | - | - | - | - | - | 0.05 | - | - | - | 0.03 | 0.07 | 0.1 | 0.13 | 0.16 | 0.19 |
Net Cash (Debt) Net Cash Growth | 40.65 | -0.48 | 3.22 | 4.05 | 5.72 | 7.43 | 12.87 | 17.65 | 21.92 | 12.04 | 17.27 | 12.07 | 13.67 | 16.72 | 21.21 | 25.41 | 32.28 | 37.94 | 45.77 | 52.04 |
Net Cash Growth | 610.36% | - | -75.01% | -77.07% | -73.89% | -38.32% | -25.49% | 46.26% | 60.38% | -27.98% | -18.60% | -52.50% | -57.67% | -55.93% | -53.66% | -51.17% | -45.52% | -39.53% | 241.12% | 476.37% |
Net Cash Per Share Net Cash Per Share Growth | 1.06 | -0.02 | 0.13 | 0.17 | 0.26 | 0.35 | 0.72 | 1.29 | 2.33 | 2.17 | 3.75 | 2.66 | 3.01 | 3.68 | 4.67 | 5.60 | 7.12 | 8.37 | 10.31 | 13.62 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -18.83 | -16.61 | -19.36 | -20.95 | -21.22 | -23.2 | -22.29 | -27.87 | -25.69 | -20.42 | -19.81 | -13.83 | -19.16 | -21.73 | -24.87 | -26.71 | -27 | -25.08 | -23.75 | -22.19 |
Capital Expenditures CapEx Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.01 | -0.07 | -0.16 | -0.16 |
Free Cash Flow Free Cash Flow Growth | -18.83 | -16.61 | -19.36 | -20.95 | -21.22 | -23.2 | -22.29 | -27.87 | -25.69 | -20.42 | -19.81 | -13.83 | -19.16 | -21.73 | -24.87 | -26.71 | -27.01 | -25.15 | -23.91 | -22.35 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Selected indicators aren't available for this stock.